WASHINGTON, DC – The US Food and Drug Administration wants to see genomic information front and center in a drug’s label.
 
The agency is poised to release guidelines for the “Clinical Pharmacology Section of Labeling for New Prescription Drugs, Content and Format,” Lawrence Lesko, director of FDA’s Office of Clinical Pharmacology and Biopharmaceutics, said at a pharmacogenetics conference held here this week by the American College of Clinical Pharmacology.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.